The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Metagenomics in Healthcare Market Research Report 2025
Synopsis
Metagenomics is the study of genetic material recovered directly from environmental samples.
The global Metagenomics in Healthcare market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Metagenomics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metagenomics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Metagenomics in Healthcare in Pharmaceutical Industries is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Metagenomics in Healthcare include Illumina, QIAGEN, PerkinElmer, Thermo Fisher Scientific and Oxford Nanopore Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metagenomics in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metagenomics in Healthcare.
Report Scope
The Metagenomics in Healthcare market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metagenomics in Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metagenomics in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Segment by Type
Sample Extraction Kits
Metagenomics Kits
Segment by Application
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metagenomics in Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Metagenomics is the study of genetic material recovered directly from environmental samples.
The global Metagenomics in Healthcare market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Metagenomics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Metagenomics in Healthcare is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Metagenomics in Healthcare in Pharmaceutical Industries is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Metagenomics in Healthcare include Illumina, QIAGEN, PerkinElmer, Thermo Fisher Scientific and Oxford Nanopore Technologies, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Metagenomics in Healthcare, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metagenomics in Healthcare.
Report Scope
The Metagenomics in Healthcare market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metagenomics in Healthcare market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metagenomics in Healthcare companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Illumina
QIAGEN
PerkinElmer
Thermo Fisher Scientific
Oxford Nanopore Technologies
Segment by Type
Sample Extraction Kits
Metagenomics Kits
Segment by Application
Pharmaceutical Industries
Biotechnology Companies
Pathology Laboratories
Academic and Research Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metagenomics in Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metagenomics in Healthcare Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sample Extraction Kits
1.2.3 Metagenomics Kits
1.3 Market by Application
1.3.1 Global Metagenomics in Healthcare Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industries
1.3.3 Biotechnology Companies
1.3.4 Pathology Laboratories
1.3.5 Academic and Research Laboratories
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metagenomics in Healthcare Market Perspective (2019-2030)
2.2 Metagenomics in Healthcare Growth Trends by Region
2.2.1 Global Metagenomics in Healthcare Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Metagenomics in Healthcare Historic Market Size by Region (2019-2024)
2.2.3 Metagenomics in Healthcare Forecasted Market Size by Region (2025-2030)
2.3 Metagenomics in Healthcare Market Dynamics
2.3.1 Metagenomics in Healthcare Industry Trends
2.3.2 Metagenomics in Healthcare Market Drivers
2.3.3 Metagenomics in Healthcare Market Challenges
2.3.4 Metagenomics in Healthcare Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metagenomics in Healthcare Players by Revenue
3.1.1 Global Top Metagenomics in Healthcare Players by Revenue (2019-2024)
3.1.2 Global Metagenomics in Healthcare Revenue Market Share by Players (2019-2024)
3.2 Global Metagenomics in Healthcare Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metagenomics in Healthcare Revenue
3.4 Global Metagenomics in Healthcare Market Concentration Ratio
3.4.1 Global Metagenomics in Healthcare Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metagenomics in Healthcare Revenue in 2023
3.5 Metagenomics in Healthcare Key Players Head office and Area Served
3.6 Key Players Metagenomics in Healthcare Product Solution and Service
3.7 Date of Enter into Metagenomics in Healthcare Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metagenomics in Healthcare Breakdown Data by Type
4.1 Global Metagenomics in Healthcare Historic Market Size by Type (2019-2024)
4.2 Global Metagenomics in Healthcare Forecasted Market Size by Type (2025-2030)
5 Metagenomics in Healthcare Breakdown Data by Application
5.1 Global Metagenomics in Healthcare Historic Market Size by Application (2019-2024)
5.2 Global Metagenomics in Healthcare Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Metagenomics in Healthcare Market Size (2019-2030)
6.2 North America Metagenomics in Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Metagenomics in Healthcare Market Size by Country (2019-2024)
6.4 North America Metagenomics in Healthcare Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metagenomics in Healthcare Market Size (2019-2030)
7.2 Europe Metagenomics in Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Metagenomics in Healthcare Market Size by Country (2019-2024)
7.4 Europe Metagenomics in Healthcare Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metagenomics in Healthcare Market Size (2019-2030)
8.2 Asia-Pacific Metagenomics in Healthcare Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Metagenomics in Healthcare Market Size by Region (2019-2024)
8.4 Asia-Pacific Metagenomics in Healthcare Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metagenomics in Healthcare Market Size (2019-2030)
9.2 Latin America Metagenomics in Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Metagenomics in Healthcare Market Size by Country (2019-2024)
9.4 Latin America Metagenomics in Healthcare Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metagenomics in Healthcare Market Size (2019-2030)
10.2 Middle East & Africa Metagenomics in Healthcare Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Metagenomics in Healthcare Market Size by Country (2019-2024)
10.4 Middle East & Africa Metagenomics in Healthcare Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Metagenomics in Healthcare Introduction
11.1.4 Illumina Revenue in Metagenomics in Healthcare Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Metagenomics in Healthcare Introduction
11.2.4 QIAGEN Revenue in Metagenomics in Healthcare Business (2019-2024)
11.2.5 QIAGEN Recent Development
11.3 PerkinElmer
11.3.1 PerkinElmer Company Detail
11.3.2 PerkinElmer Business Overview
11.3.3 PerkinElmer Metagenomics in Healthcare Introduction
11.3.4 PerkinElmer Revenue in Metagenomics in Healthcare Business (2019-2024)
11.3.5 PerkinElmer Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Metagenomics in Healthcare Introduction
11.4.4 Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Oxford Nanopore Technologies
11.5.1 Oxford Nanopore Technologies Company Detail
11.5.2 Oxford Nanopore Technologies Business Overview
11.5.3 Oxford Nanopore Technologies Metagenomics in Healthcare Introduction
11.5.4 Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2019-2024)
11.5.5 Oxford Nanopore Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Metagenomics in Healthcare Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sample Extraction Kits
Table 3. Key Players of Metagenomics Kits
Table 4. Global Metagenomics in Healthcare Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Metagenomics in Healthcare Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Metagenomics in Healthcare Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Metagenomics in Healthcare Market Share by Region (2019-2024)
Table 8. Global Metagenomics in Healthcare Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Metagenomics in Healthcare Market Share by Region (2025-2030)
Table 10. Metagenomics in Healthcare Market Trends
Table 11. Metagenomics in Healthcare Market Drivers
Table 12. Metagenomics in Healthcare Market Challenges
Table 13. Metagenomics in Healthcare Market Restraints
Table 14. Global Metagenomics in Healthcare Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Metagenomics in Healthcare Market Share by Players (2019-2024)
Table 16. Global Top Metagenomics in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metagenomics in Healthcare as of 2023)
Table 17. Ranking of Global Top Metagenomics in Healthcare Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Metagenomics in Healthcare Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metagenomics in Healthcare Product Solution and Service
Table 21. Date of Enter into Metagenomics in Healthcare Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metagenomics in Healthcare Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Metagenomics in Healthcare Revenue Market Share by Type (2019-2024)
Table 25. Global Metagenomics in Healthcare Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Metagenomics in Healthcare Revenue Market Share by Type (2025-2030)
Table 27. Global Metagenomics in Healthcare Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Metagenomics in Healthcare Revenue Market Share by Application (2019-2024)
Table 29. Global Metagenomics in Healthcare Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Metagenomics in Healthcare Revenue Market Share by Application (2025-2030)
Table 31. North America Metagenomics in Healthcare Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Metagenomics in Healthcare Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Metagenomics in Healthcare Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Metagenomics in Healthcare Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Metagenomics in Healthcare Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Metagenomics in Healthcare Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Metagenomics in Healthcare Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Metagenomics in Healthcare Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Metagenomics in Healthcare Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Metagenomics in Healthcare Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Metagenomics in Healthcare Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Metagenomics in Healthcare Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Metagenomics in Healthcare Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Metagenomics in Healthcare Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Metagenomics in Healthcare Market Size by Country (2025-2030) & (US$ Million)
Table 46. Illumina Company Detail
Table 47. Illumina Business Overview
Table 48. Illumina Metagenomics in Healthcare Product
Table 49. Illumina Revenue in Metagenomics in Healthcare Business (2019-2024) & (US$ Million)
Table 50. Illumina Recent Development
Table 51. QIAGEN Company Detail
Table 52. QIAGEN Business Overview
Table 53. QIAGEN Metagenomics in Healthcare Product
Table 54. QIAGEN Revenue in Metagenomics in Healthcare Business (2019-2024) & (US$ Million)
Table 55. QIAGEN Recent Development
Table 56. PerkinElmer Company Detail
Table 57. PerkinElmer Business Overview
Table 58. PerkinElmer Metagenomics in Healthcare Product
Table 59. PerkinElmer Revenue in Metagenomics in Healthcare Business (2019-2024) & (US$ Million)
Table 60. PerkinElmer Recent Development
Table 61. Thermo Fisher Scientific Company Detail
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific Metagenomics in Healthcare Product
Table 64. Thermo Fisher Scientific Revenue in Metagenomics in Healthcare Business (2019-2024) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Oxford Nanopore Technologies Company Detail
Table 67. Oxford Nanopore Technologies Business Overview
Table 68. Oxford Nanopore Technologies Metagenomics in Healthcare Product
Table 69. Oxford Nanopore Technologies Revenue in Metagenomics in Healthcare Business (2019-2024) & (US$ Million)
Table 70. Oxford Nanopore Technologies Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metagenomics in Healthcare Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Metagenomics in Healthcare Market Share by Type: 2023 VS 2030
Figure 3. Sample Extraction Kits Features
Figure 4. Metagenomics Kits Features
Figure 5. Global Metagenomics in Healthcare Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Metagenomics in Healthcare Market Share by Application: 2023 VS 2030
Figure 7. Pharmaceutical Industries Case Studies
Figure 8. Biotechnology Companies Case Studies
Figure 9. Pathology Laboratories Case Studies
Figure 10. Academic and Research Laboratories Case Studies
Figure 11. Others Case Studies
Figure 12. Metagenomics in Healthcare Report Years Considered
Figure 13. Global Metagenomics in Healthcare Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Metagenomics in Healthcare Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Metagenomics in Healthcare Market Share by Region: 2023 VS 2030
Figure 16. Global Metagenomics in Healthcare Market Share by Players in 2023
Figure 17. Global Top Metagenomics in Healthcare Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metagenomics in Healthcare as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Metagenomics in Healthcare Revenue in 2023
Figure 19. North America Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Metagenomics in Healthcare Market Share by Country (2019-2030)
Figure 21. United States Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Metagenomics in Healthcare Market Share by Country (2019-2030)
Figure 25. Germany Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Metagenomics in Healthcare Market Share by Region (2019-2030)
Figure 33. China Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Metagenomics in Healthcare Market Share by Country (2019-2030)
Figure 41. Mexico Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Metagenomics in Healthcare Market Share by Country (2019-2030)
Figure 45. Turkey Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Metagenomics in Healthcare Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Illumina Revenue Growth Rate in Metagenomics in Healthcare Business (2019-2024)
Figure 48. QIAGEN Revenue Growth Rate in Metagenomics in Healthcare Business (2019-2024)
Figure 49. PerkinElmer Revenue Growth Rate in Metagenomics in Healthcare Business (2019-2024)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Metagenomics in Healthcare Business (2019-2024)
Figure 51. Oxford Nanopore Technologies Revenue Growth Rate in Metagenomics in Healthcare Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
